LivaNova PLC

LIVN

$64.95

Name : LivaNova PLC

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $3,546,628,864.00

EPSttm : -3.98

LivaNova PLC

$64.95

0.51%

$0.33

Float Short %

3.94

Margin Of Safety %

-29

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.08

EPS Last/This Y

2.69

EPS This/Next Y

0.28

Price

64.97

Target Price

71.2

Analyst Recom

1.64

Performance Q

21.7

Relative Volume

0.77

Beta

0.97

Ticker: LIVN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-10	LIVN	64.07	0.25	0.18	935
2025-12-11	LIVN	63.94	0.24	1.00	944
2025-12-12	LIVN	62.77	0.24	999.99	943
2025-12-15	LIVN	63.06	0.25	999.99	944
2025-12-16	LIVN	63.07	0.27	999.99	966
2025-12-17	LIVN	63.08	0.27	999.99	966
2025-12-18	LIVN	62.08	0.27	999.99	966
2025-12-19	LIVN	62.81	0.29	0.00	976
2025-12-22	LIVN	63.08	0.29	0.00	976
2025-12-23	LIVN	62.97	0.46	999.99	415
2025-12-26	LIVN	62.9	0.46	999.99	415
2025-12-29	LIVN	62.41	0.46	999.99	416
2025-12-30	LIVN	62.23	0.46	999.99	416
2025-12-31	LIVN	61.53	0.46	999.99	416
2026-01-02	LIVN	60.64	0.46	999.99	416
2026-01-05	LIVN	63.25	0.47	0.00	417
2026-01-06	LIVN	64.12	0.47	999.99	417
2026-01-07	LIVN	64.62	0.49	3.00	423
2026-01-08	LIVN	64.93	0.51	0.00	431
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-10	LIVN	64.07	0.1	322.0	3.86
2025-12-11	LIVN	63.95	0.1	315.4	3.86
2025-12-12	LIVN	62.75	0.1	312.3	3.86
2025-12-15	LIVN	63.06	0.1	316.7	3.86
2025-12-16	LIVN	63.06	0.1	315.7	3.86
2025-12-17	LIVN	63.06	0.1	315.7	3.86
2025-12-18	LIVN	62.12	0.1	312.8	3.86
2025-12-19	LIVN	62.79	0.1	317.9	3.86
2025-12-22	LIVN	62.82	-0.1	315.8	3.86
2025-12-23	LIVN	63.31	-0.1	316.2	3.86
2025-12-26	LIVN	62.86	-0.1	315.1	3.86
2025-12-29	LIVN	62.45	-0.1	314.5	3.86
2025-12-30	LIVN	62.23	-0.1	315.0	3.86
2025-12-31	LIVN	61.54	-0.1	313.5	3.86
2026-01-02	LIVN	60.62	-0.1	313.0	3.86
2026-01-05	LIVN	63.31	-0.1	324.0	3.86
2026-01-06	LIVN	64.12	-0.1	318.4	3.86
2026-01-07	LIVN	64.56	-0.1	317.0	3.86
2026-01-08	LIVN	64.97	-0.1	316.8	3.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-10	LIVN	-0.88	-1.65	4.21
2025-12-11	LIVN	-0.88	-1.65	4.21
2025-12-12	LIVN	-0.88	-1.65	4.21
2025-12-15	LIVN	-0.88	-1.68	4.21
2025-12-16	LIVN	-0.88	-1.68	4.21
2025-12-17	LIVN	-0.88	-1.68	4.21
2025-12-18	LIVN	-0.88	-1.68	4.21
2025-12-19	LIVN	-0.88	-1.68	4.21
2025-12-22	LIVN	-0.88	-0.70	4.21
2025-12-23	LIVN	-0.86	-0.70	4.21
2025-12-26	LIVN	-0.86	-0.70	3.95
2025-12-29	LIVN	-0.86	-0.49	3.95
2025-12-30	LIVN	-0.86	-0.49	3.95
2025-12-31	LIVN	-0.86	-0.49	3.95
2026-01-02	LIVN	-0.86	-0.49	3.95
2026-01-05	LIVN	-0.86	-0.49	3.94
2026-01-06	LIVN	-0.99	-0.49	3.94
2026-01-07	LIVN	-0.99	-0.49	3.94
2026-01-08	LIVN	-0.99	-0.49	3.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

0.81

Avg. EPS Est. Next Quarter

0.89

Insider Transactions

-0.99

Institutional Transactions

-0.49

Beta

0.97

Average Sales Estimate Current Quarter

353

Average Sales Estimate Next Quarter

339

Fair Value

46.05

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

30.8

Max Drawdown 5-Year %

-63.5

Target Price

71.2

P/E

Forward P/E

15.69

PEG

1.58

P/S

2.63

P/B

3.06

P/Free Cash Flow

18.53

EPS

-4.01

Average EPS Est. Cur. Y

3.86

EPS Next Y. (Est.)

4.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-16.12

Relative Volume

0.77

Return on Equity vs Sector %

-46.1

Return on Equity vs Industry %

-36.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

316.8

LivaNova PLC

Sector: Healthcare

Industry: Medical Devices

Employees: 2900

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

stock quote shares LIVN – LivaNova PLC Stock Price stock today

news today LIVN – LivaNova PLC stock forecast ,stock prediction 2023 2024 2025

marketwatch LIVN – LivaNova PLC yahoo finance google finance

stock history LIVN – LivaNova PLC invest stock market

stock prices LIVN premarket after hours

ticker LIVN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: LIVN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y